Overview

Acceleration 2011

Where Biotech, Pharma and Medical Device executives and entrepreneurs explore how investment and innovation lead to business acceleration. An outstanding line-up of speakers is coming together for this conference to examine current issues and trends in early-stage development among life science companies. Join us to hear compelling experiences, perspectives and insights from industry leaders and innovators.

Presented by Nutter McClennen & Fish LLP co-presented by Halloran Consulting Group and PwC

November 17, 2011
3:00-7:00 p.m.
Nutter Conference Center
Boston, Massachusetts

Keynote Speakers:

Michelle Dipp, M.D., Ph.D., Longwood Founders Fund
Patrice M. Milos, Ph.D., Pfizer, Centers for Therapeutic Innovation, Boston

Who benefits from attending:
-
Entrepreneurs in medical device, pharma and biotech companies
- Angel, Venture Capital and Private Equity life science investors
- C-level executives and business development professionals from large medical device, pharma and biotech companies

Panel I – How Lean is Too Lean?

Bruce L. Booth, D.Phil., Atlas Venture
Stephen DeMarco, PwC
Bill Gruber, Solace Therapeutics
Laurie Halloran, Halloran Consulting Group
Moderated by Michelle L. Basil,
Nutter McClennen & Fish LLP

Panel II – Are Big Pharma and Big Device The New Accelerators?

Brian M. Gallagher, Jr., Ph.D., SR One Ltd.
Donald D. Haut, Jr., Ph.D., Smith & Nephew
Julius (Jay) Knowles, MS, MBA, Novartis Institutes for BioMedical Research
Greg Miller, Concert Pharmaceuticals, Inc.
Moderated by Maria D. Buckley,
Nutter McClennen & Fish LLP

Location:
Nutter McClennen & Fish LLP
Nutter Conference Center
Seaport West
155 Seaport Boulevard, 5th floor
Boston, MA 02210
DIRECTIONS & PARKING

Registration:
ACCELERATION 2011 is a free event and is available by invitation only. If you have received an invitation, please click here to register.

If you would like to request an invitation, please contact us at acceleration@nutter.com or 617-439-2985.

 

Comments are closed.